Janus Henderson Group
FMTX

Janus Henderson Group’s Forma Therapeutics Holdings, Inc. Common Stock FMTX Stock Holding History

Janus Henderson Group’s Portfolio FMTX Stock Details FMTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-776,845
Closed -$19.3M – 2237
2021
Q2 		$19.3M Sell
776,845
-69,378
-8% -$1.86M 0.01% 791
2021
Q1 		$23.7M Sell
846,223
-268,486
-24% -$9.69M 0.01% 733
2020
Q4 		$37.8M Sell
1,114,709
-364,633
-25% -$15.9M 0.02% 611
2020
Q3 		$72.2M Buy
1,479,342
+488,297
+49% +$19.7M 0.04% 403
2020
Q2 		$46.1M Buy
+991,045
New +$43M 0.03% 508

Other funds holding FMTX

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return

Janus Henderson Group's FMTX Position: Q3 2021 in Review

Janus Henderson Group sold out of Forma Therapeutics Holdings, Inc. Common Stock (FMTX) in Q3 2021, closing a stake of 776,845 shares — an estimated $19.3M sold.

Janus Henderson Group first reported a position in FMTX in Q2 2020 and held it in 5 quarters. The position peaked at $72.2M in Q3 2020. 89 funds tracked by Wall St. Rank hold FMTX as of Q3 2021.

  • Janus Henderson Group reported no remaining Forma Therapeutics Holdings, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Janus Henderson Group sold 776,845 Forma Therapeutics Holdings, Inc. Common Stock shares in Q3 2021, an estimated $19.3M.
  • Janus Henderson Group first reported a position in Forma Therapeutics Holdings, Inc. Common Stock in Q2 2020 and held it in 5 quarters.
  • Janus Henderson Group's Forma Therapeutics Holdings, Inc. Common Stock position peaked at $72.2M in Q3 2020.
  • 89 funds tracked by Wall St. Rank held Forma Therapeutics Holdings, Inc. Common Stock as of Q3 2021.

Based on Janus Henderson Group's 13F filing for Q3 2021, filed 16 Nov 2021.